Reta GLP3 refers to Retatrutide , a synthetic tripleagonist peptide that simultaneously targets the GLP1 (glucagonlike peptide1) , GIP (glucosedependent insulinotropic polypeptide) , and glucagon receptors to model and investigate complex metabolic regulation, appetite control, energy expenditure and weight modulation pathways in laboratory research settings
Compounded Lipo B contains the same active ingredients (methylcobalamin, methionine, inositol, choline, L-carnitine) as brand-name formulations but is prepared by state-licensed compounding pharmacies or FDA-registered 503B facilities rather than manufactured as an FDA-approved drug product
Big Update for Healthcare in India Semaglutide Patent Expiry (March-2026) One of the most significant upcoming patent expiries is Semaglutide, a blockbuster drug widely used for Type-2 Diabetes and Obesity (brands such as Ozempic and Wegovy)
Should everyone on Ozempic or Mounjaro take supplements
